Investor Relations

Home/Investor Relations

Overview

SourceBio has achieved significant growth in revenues and adjusted EBITDA over the last two years. In the year ended 31 December 2021 the Group generated revenue of £92.4 million (unaudited), an increase of 82% on 2020 revenues of £50.7 million (audited) and adjusted EBITDA approximately 70% higher than the £14.2 million (audited) generated In the year ended 31 December 2020. The Group delivered revenues of £21.2 million and adjusted EBITDA of £3.0 million in the year ended 31 December 2019. The Directors believe that the Group is well positioned to capitalise on rapidly growing and attractive market opportunities across its three core business divisions.

The Group employs over 300 employees across six sites globally, in the UK, Ireland and North America with headquarters in Nottingham, UK. It benefits from an experienced Executive Management team with a strong background in the Life Sciences, Healthcare and Technology sectors.